Carvejohn 12.5 mg Johnlee Pharmaceuticals
| Features | |
| Also known as | Coreg |
| Blood pressure | Lowers blood pressure |
| Chemical name | 1-(9H-Carbazol-4-yloxy)-3-[[2-(2-methoxyphenoxy)ethyl]amino]-2-propanol |
| Dosage (medical) | Typically 12.5 mg once daily initially, then increased to 25 mg twice daily as tolerated |
| Dosage (sports) | Not applicable |
| Effects | Reduces heart rate and blood pressure, improves blood flow |
| Formula | C24H26N2O4 |
| Half-life | 7-10 hours |
| Hepatotoxicity | Low risk but can occur, particularly in patients with pre-existing liver conditions |
| Lab Test | No specific lab test required regularly, liver function tests may be monitored |
| Main action | Antihypertensive, antianginal, antiarrhythmic |
| Side effects | Dizziness, fatigue, hypotension, diarrhea, weight gain |
| Storage conditions | Store at controlled room temperature, away from moisture and heat |
| Strength | 12.5mg |
| Substance class | Beta-blocker with alpha-blocking activity |
| Trade name | Coreg |
| Use in sports | Not typically used in sports |
| Water Retention | Minimal |
| Manufacturer | Johnlee Pharmaceuticals Pvt. Ltd. |
| Packing | 10 tabs/blister |